NeoGenomics Q2 2026 Revenue Rises 11 Percent to $201.7 Million on Strong NGS Results
NeoGenomics reports Q2 2026 revenue of $201.7 million, an 11% increase, led by 26% growth in NGS revenue. Management raised full-year revenue guidance for 2026.
ALFA USA News
Straight from the SEC filing
Every story from SEC filings, newest first.
NeoGenomics reports Q2 2026 revenue of $201.7 million, an 11% increase, led by 26% growth in NGS revenue. Management raised full-year revenue guidance for 2026.
Chiron Real Estate Inc. (XRN) closes the $173.2 million acquisition of The Pinnacle North Bethesda, funded largely by $171 million in credit facility debt.
WEBTOON Entertainment (WBTN) announces a November 16 launch for the new Marvel Comics app featuring 35,000 digital titles and vertical-scroll reading technology.
CECO Environmental (CECO) will move its primary listing to the Texas Stock Exchange on October 19, 2026, marking the first multi-industrial transfer to the TXSE.
Ennis, Inc. (EBF) reports Q2-2026 revenue of $102.01M, though net income fell 28.6% to $9.39M due to a prior-year legal settlement gain not recurring in 2026.
Duos Technologies (DUOT) completes $130.7 million divestiture of its GPU-as-a-Service unit to Axe Compute, transitioning to a pure-play AI colocation landlord.
iRhythm Holdings (IRTC) has finalized its $237.5 million cash acquisition of Vital Connect, expanding its cardiac monitoring platform into the MCT market today.
Leidos (LDOS) completes joint venture with Altaris, merging SES/IA units with Analogic. Leidos retains 41.5% stake following the October 5, 2026 closing.
RXO, Inc. enters a $5.8 billion merger agreement with C.H. Robinson, offering stockholders $30.25 per share in a deal set to close in the first half of 2027.
Flex Ltd. enters agreement for a $2.0 billion convertible preferred investment in its Axiom subsidiary to fund the EPC Power acquisition and 2027 spin-off.
EuroDry Ltd. reports H1-2026 net income of $7.36 million, a 203.4% increase over 2025, driven by Time Charter Equivalent rates doubling to $17,452 per vessel day.
Vaxcyte reports VAX-31 met all primary endpoints in the OPUS-1 Phase 3 trial, demonstrating noninferiority to Prevnar 20 and Capvaxive for adult use at age 50+.
Distribution Solutions Group (DSGR) launches a $700 million senior notes offering to fund its take-private merger with LKCM Headwater at $35.00 per share in cash
Matador Resources (MTDR) completes the $1.275 billion acquisition of Paloma Permian, adding 16,500 net acres and 156 drilling locations in the Delaware Basin.
Harrow, Inc. (HROW) completes the $30 million acquisition of TYRVAYA nasal spray from Viatris, expanding its dry eye disease portfolio with worldwide rights.
PTC Inc. (PTC) enters definitive agreement to be acquired by Schneider Electric for $205 per share, valuing the industrial software leader at $22.6 billion.
Advanced Drainage Systems (WMS) enters $530 million deal to acquire StormTrap Investments, expanding its stormwater storage portfolio and market reach. (155 chars)
GEO Group sells its 2,644-bed Adelanto Complex to the Department of Homeland Security for $950 million, allocating $705 million in net proceeds for debt reduction.
ESCO Technologies (NYSE: ESE) closes its $2.3B acquisition of Megger Group, utilizing a mix of $922M cash and 5.1M shares to expand utility solutions footprint.
BioAge Labs (BIOA) initiates Phase 2 QUELL-DME trial for BGE-102 in diabetic macular edema, with topline results for the 180-patient study expected in H2 2027.